Genetic variants of proteins from the renin angiotensin system are associated with pressure load cardiac hypertrophy

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 6-7, 1996, Pages 587-590

  Wong, K K ^a   Summers, K M ^a   Burstow, D J ^a   West, M J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

angiotensin converting enzyme gene; angiotensin II type 1 receptor gene; angiotensinogen gene; aortic stenosis; cardiac hypertrophy

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; RENIN;

ADULT; AGED; AORTA STENOSIS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC LINKAGE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE WALL; HUMAN; MAJOR CLINICAL STUDY; MALE; RECEPTOR GENE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0030013939     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb02788.x     Document Type: Conference Paper

References (15)

1. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in human left ventricle. J. Clin. Invest. 1975; 56: 56-64.
2. Krayenbuehl HP, Otto HM, Monrad ES, Schneider J, Mall G, Turina M. Left ventricular myocardial structure in aortic valve disease before, intermediate and late after aortic valve replacement. Circulation 1989; 79: 744-55.
3. Devereux RB. Hypertensive cardiac hypertrophy: Pathophysiology and clinical characteristics. In: Laragh JH, Brenner BM (eds). Hypertension: Pathophysiology, Diagnosis and Management. Raven Press Ltd, New York. 1990; 359-77.
4. Griendling KK, Murphy TJ, Alexander RW. Molecular biology of the renin angiotensin system. Circulation 1993; 87: 1816-28.
5. Bruckschlegal G, Holmer SR, Jandeleit K et al. Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats. Hypertension 1995; 25: 250-9.
6. Brener SJ, Duffy CI, Thomas JD, Steward WJ. Progression of aortic stenosis in 394 patients: Relation to changes in myocardial and mitral valve dysfunction. J. Am. Coll. Cardiol. 1995; 25: 305-10.
7. Nishimura RA, Tajik AJ. Quantitative hemodynamics by Doppler echocardiography: A noninvasive alternative to cardiac catheterization. Prog. Cardiovasc. Dis. 1994; 36: 309-42.
8. Caulfield M, Lavender P, Farrall M et al. Linkage of the angiotensinogen gene to essential hypertension. N. Engl. J. Med. 1994; 330: 1629-33.
9. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCPI; dipeptidyl cardoxypeptidase). Nucleic Acids Res. 1992; 20: 1433.
10. Davies E, Bonnardeaux A, Lathrop GM, Corvol P, Clauser E, Soubrier F. Angiotensin II (type I) receptor locus: CA repeat polymorphism and genetic mapping. Hum. Mol. Genet. 1994; 3: 838.
11. Jeunemaitre X, Soubrier F, Kotelevtsev YV et al. Molecular basis of human hypertension: Role of angiotensinogen. Cell 1992; 71: 169-80.
12. Tiret L, Rigat B, Visvikis S et al. Evidence from combined segregation and linkage analysis, that a variant of the angiotensin-I converting enzyme (ACE) gene controls plasma ACE levels. Am. J. Hum. Genet. 1992; 51: 197-205.
13. Ueda S, Elliott HL, Morton JJ, Connell JMC. Enhanced pressor response to angiotensin 1 in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 1995; 25: 1266-9.
14. Stoll M, Meffert S, Stroth U, Unger T. Growth or antigrowth: Angiotensin and the endothelium. J. Hypertens. 1996; 13: 1529-34.
15. Prasad N, O'Kane KPJ, Johnstone HA et al. The relationship between blood pressure and left ventricular mass in essential hypertension is observed only in the presence of the angiotensin converting enzyme deletion allele. Q. J. Med. 1994; 87: 659-62.